Bitangcor, Lj Rubia .
HRN: 23-10-23 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2023
CEFUROXIME 1.5GM (VIAL)
05/29/2023
06/06/2023
IV
1.5g
Q8
UTI
Waiting Final Action
05/30/2023
CEFUROXIME 500MG (TAB)
05/30/2023
06/06/2023
PO
1 Tab
Bid
NSVD W RMLE
Waiting Final Action